IP Library Granted Patent US 12,171,899
Granted Patent B2
US 12,171,899 · App. 17/418,731 · Granted Dec 24, 2024

Radiation sterilization resistant adhesive

Inventor: Takeshi Ito (Sagamihara, JP)
Assignee: Solventum Intellectual Properties Company
A61L24/043C09J7/35C09J133/10C09J193/04C09J2433/00C09J2493/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,171,899
App. No.
17/418,731
Granted
Dec 24, 2024
Kind
B2
Abstract

Provided is a radiation sterilization resistant adhesive agent layer capable of reducing or preventing a decrease in wettability of an adhesive after radiation sterilization treatment. The adhesive can be used with a medical implement, for example medical implements that are sterilized. The adhesive agent layer includes a (meth)acrylic polymer and a wettability stabilizer, and the wettability stabilizer is at least one selected from a rosin ester resin, a terpene phenol resin, and hydrides thereof.

Claims (28)

1. A medical member for skin application comprising:

an adhesive agent layer resistant to radiation sterilization, the adhesive agent layer comprising:

a (meth)acrylic polymer having one or more UV crosslinkable site selected from a benzophenone group, a benzyl group, an o-benzoylbenzoate group, a thioxanthone group, a 3-ketocoumarin group, a 2-ethylanthraquinone group, and a camphor quinone group; and

a wettability stabilizer, wherein the wettability stabilizer is selected from a rosin ester resin, a terpene phenol resin, and hydrides thereof.

2. The medical member of claim 1 , further comprising:

a medical implement.

3. The medical member of claim 2 , wherein the medical implement is at least one selected from a backing, dosing equipment, communication equipment, testing equipment, and protective equipment.

4. The medical member of claim 1 , wherein the wettability stabilizer is selected from a terpene phenol resin and a hydride thereof.

5. The medical member of claim 1 , wherein the wettability stabilizer is present in an amount from 15 to 60 mass % with respect to the weight of the adhesive agent layer.

6. The medical member of claim 1 , wherein the adhesive agent layer is a hot melt adhesive.

7. The medical member of claim 1 , wherein a thickness of the adhesive agent layer is from 10 to 300 μm.

8. The medical member of claim 1 , the (meth)acrylic polymer derived from:

one or more C 1-20 alkyl (meth)acrylate monomer represented by one of formulae:

CH 2 ═CH—COO—R 1 or CH 2 ═C(CH 3 )—COO—R 1 ,

wherein: R 1 is a linear, branched, or cyclic alkyl group having from 1 to 20 carbon atoms;

one or more polar unsaturated monomer having a polar group and a vinylcarbonyl group characterized by a formula:

CH 2 ═CH—C(═O)—; and

one or more (meth)acrylate monomer having a UV crosslinkable group selected from a benzophenone, a benzyl, an o-benzoylbenzoate, a thioxanthone, a 3-ketocoumarin, a 2-ethylanthraquinone, and a camphor quinone.

9. The medical member of claim 8 , the one or more C 1-20 alkyl (meth)acrylate monomer selected from methyl (meth)acrylate, ethyl (meth)acrylate, n-butyl (meth)acrylate, hexyl (meth)acrylate, n-octyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, isobutyl (meth)acrylate, tert-butyl (meth)acrylate, cyclohexyl (meth)acrylate, isobornyl (meth)acrylate, and dicyclopentanyl (meth)acrylate.

10. The medical member of claim 8 , the one or more polar unsaturated monomer selected from:

a hydroxyl group-containing unsaturated monomer selected from 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 4-hydroxybutyl (meth)acrylate, polyethylene glycol (meth)acrylate, and polypropylene glycol (meth)acrylate;

a carboxyl group-containing unsaturated monomer selected from acrylic acid, itaconic acid, maleic acid, and fumaric acid;

a carbamoyl group-containing unsaturated monomer selected from acrylamide;

an amino group-containing monomer selected from N,N-dimethylaminoethyl (meth)acrylate, N,N-diethylaminoethyl (meth)acrylate, and N,N-dimethylaminopropyl (meth)acrylate; and

an epoxy group-containing unsaturated monomer selected from glycidyl (meth)acrylate.

11. The medical member of claim 8 , the one or more (meth)acrylate monomer having a UV crosslinkable group selected from 4-acryloyloxybenzophenone, 4-acryloyloxyethoxybenzophenone, 4-acryloyloxy-4′-methoxybenzophenone, 4-acryloyloxyethoxy-4′-methoxybenzophenone, 4-acryloyloxy-4′-bromobenzophenone, 4-acryloyloxyethoxy-4′-bromobenzophenone, 4-methacryloyloxybenzophenone, 4-methacryloyloxyethoxybenzophenone, 4-methacryloyloxy-4′-methoxybenzophenone, 4-methacryloyloxyethoxy-4′-methoxybenzophenone, 4-methacryloyloxy-4′-bromobenzophenone, and 4-methacryloyloxyethoxy-4′-bromobenzophenone.

12. The medical member of claim 8 , the (meth)acrylic polymer derived from 2-ethylhexyl acrylate, acrylic acid, and acryloxybenzophenone.

13. The medical member of claim 12 , the 2-ethylhexyl acrylate, acrylic acid, and acryloxybenzophenone present in a weight ratio of 96.5:3.5:0.5.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066443/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2021
From: ITO, TAKESHI
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 056691/0026 →
Priority Claims (1)
JP 2018-245837 · Dec 27, 2018 · national
Continuity (1)
Related Publication 20220072194A1 · Mar 10, 2022